29.6.2012   

RO

Jurnalul Oficial al Uniunii Europene

C 190/1

Rezumatul deciziilor Uniunii Europene privind autorizațiile de introducere pe piață pentru medicamentele de la 1 mai 2012 până la 31 mai 2012

(Publicat în temeiul articolului 13 sau al articolului 38 din Regulamentul (CE) nr. 726/2004 al Parlamentului European și al Consiliului  (1) )

2012/C 190/01

—   Emiterea unei autorizații de introducere pe piață (articolul 13 din Regulamentul (CE) nr. 726/2004 al Parlamentului European și al Consiliului): Acceptat

Data deciziei

Denumirea medicamentului

DCI (Denumirea Comună Internațională)

Titularul autorizației de introducere pe piață

Numărul de înregistrare în Registrul comunitar

Formă farmaceutică

Codul ATC (Codul Anatomic-Terapeutic-Chimic)

Data notificării

7.5.2012

Riluzole Zentiva

Riluzol

Aventis Pharma S.A.

20 avenue Raymond Aron,

F-92165 Antony Cedex,

France

EU/1/12/768/001

Comprimat filmat

N07XX02

10.5.2012

10.5.2012

Pixuvri

pixantronă

CTI Life Sciences Ltd

Biopark, Broadwater Road,

Welwyn Garden City,

Hertfordshire AL73AX,

United Kingdom

EU/1/12/764/001

Pulbere pentru concentrat pentru soluție perfuzabilă

L01DB11

14.5.2012

22.5.2012

Docetaxel Accord

Docetaxel

Accord Healthcare Limited

Sage house, 319 Pinner road,

North Harrow,

Middlesex HA1 4HF

United Kingdom

EU/1/12/769/001-003

Concentrat pentru soluție perfuzabilă

L01CD02

25.5.2012

22.5.2012

Docetaxel Kabi

Docetaxel

Fresenius Kabi Oncology Plc.

Lion Court, Farnham Road,

Bordon,

Hampshire,

GU35 0NF,

United Kingdom

EU/1/12/770/001-004

Concentrat pentru soluție perfuzabilă

L01CD02

25.5.2012


—   Modificarea unei autorizații de introducere pe piață (articolul 13 din Regulamentul (CE) nr. 726/2004 al Parlamentului European și al Consiliului): Acceptat

Data deciziei

Denumirea medicamentului

Titularul autorizației de introducere pe piață

Numărul de înregistrare în Registrul comunitar

Data notificării

7.5.2012

Intanza

Sanofi Pasteur MSD SNC

8, rue Jonas Salk,

Lyon 69007,

France

EU/1/08/505/001-003

9.5.2012

7.5.2012

Ovitrelle

Merck Serono Europe Limited

56, Marsh Wall,

London E14 9TP,

United Kingdom

EU/1/00/165/001-003

9.5.2012

10.5.2012

Abilify

Otsuka Pharmaceutical Europe Ltd

Hunton House, Highbridge Business Park,

Oxford Road,

Uxbridge,

Middlesex UB8 1HU,

United Kingdom

EU/1/04/276/001-020

EU/1/04/276/024-036

14.5.2012

10.5.2012

CoAprovel

Sanofi Pharma Bristol-Myers Squibb SNC

174 avenue de France -

75013 Paris,

France

EU/1/98/086/001-034

14.5.2012

10.5.2012

Ibandronic Acid Teva

Teva Pharma B.V.

Computerweg 10,

3542 DR Utrecht,

Nederland

EU/1/10/642/001-004

14.5.2012

10.5.2012

Irbesartan / Hydrochlorothiazide Teva

Teva Pharma B.V.

Computerweg 10,

3542 DR Utrecht,

Nederland

EU/1/09/583/001-072

14.5.2012

10.5.2012

Siklos

ADDMEDICA

101, rue Saint Lazare,

Paris 75009,

France

EU/1/07/397/001-004

14.5.2012

10.5.2012

Telmisartan Actavis

Actavis Group PTC ehf.

Reykjavíkurvegi 76 78,

220 Hafnarfjörður,

Iceland

EU/1/10/639/001-030

14.5.2012

10.5.2012

Telmisartan Teva

Teva Pharma B.V.

Computerweg 10,

3542 DR Utrecht,

Nederland

EU/1/09/610/001-060

14.5.2012

10.5.2012

Trobalt

Glaxo Group Limited

Berkeley Avenue,

Greenford,

Middlesex UB6 0NN,

United Kingdom

EU/1/11/681/001-013

14.5.2012

14.5.2012

Brilique

AstraZeneca AB

Södertälje S 151 85,

Sverige

EU/1/10/655/001-006

16.5.2012

14.5.2012

Invega

Janssen-Cilag International NV

Turnhoutseweg, 30 -

2340 Beerse -

België

EU/1/07/395/001-095

16.5.2012

14.5.2012

JEVTANA

SANOFI

174, avenue de France,

F-75013 Paris,

France

EU/1/11/676/001

16.5.2012

14.5.2012

Luveris

Merck Serono Europe Limited

56, Marsh Wall,

London E14 9TP,

United Kingdom

EU/1/00/155/001-003

16.5.2012

14.5.2012

Possia

AstraZeneca AB

Södertälje S 151 85,

Sverige

EU/1/10/656/001-006

16.5.2012

14.5.2012

TOBI Podhaler

Novartis Europharm Limited

Wimblehurst Road,

Horsham,

West Sussex, RH12 5AB,

United Kingdom

EU/1/10/652/001-003

16.5.2012

15.5.2012

Mircera

Roche Registration Limited

6 Falcon Way,

Shire Park,

Welwyn Garden City,

AL7 1TW,

United Kingdom

EU/1/07/400/008-013

EU/1/07/400/017-024

17.5.2012

15.5.2012

Topotecan Hospira

Hospira UK Limited

Queensway,

Royal Leamington Spa,

Warwickshire CV31 3RW,

United Kingdom

EU/1/10/633/001-002

17.5.2012

15.5.2012

Vizarsin

KRKA, d.d., Novo mesto

Šmarješka cesta 6,

8501 Novo mesto,

Slovenija

EU/1/09/551/001-027

17.5.2012

22.5.2012

Aerinaze

Merck Sharp & Dohme Ltd

Hertford Road,

Hoddesdon,

Hertfordshire EN11 9BU,

United Kingdom

EU/1/07/399/001-006

25.5.2012

22.5.2012

Fampyra

Biogen Idec Limited

Innovation House,

70 Norden Road,

Maidenhead,

Berkshire SL6 4AY,

United Kingdom

EU/1/11/699/001-004

25.5.2012

22.5.2012

Gardasil

Sanofi Pasteur MSD, SNC

8, rue Jonas Salk,

69007 Lyon,

France

EU/1/06/357/001-008

EU/1/06/357/018-021

25.5.2012

22.5.2012

HALAVEN

Eisai Europe Limited

European Knowledge Centre,

Mosquito Way,

Hatfield,

Hertsforshire AL10 9SN,

United Kingdom

EU/1/11/678/001-002

25.5.2012

22.5.2012

Hizentra

CSL Behring GmbH

Emil-von-Behring-Strasse 76,

35041 Marburg,

Deutschland

EU/1/11/687/001-012

25.5.2012

22.5.2012

IDflu

Sanofi Pasteur SA

2, avenue Pont Pasteur,

F-69007 Lyon,

France

EU/1/08/507/001-003

25.5.2012

22.5.2012

Pergoveris

Merck Serono Europe Limited

56, Marsh Wall,

London E14 9TP,

United Kingdom

EU/1/07/396/001-003

25.5.2012

22.5.2012

Silgard

Merck Sharp & Dohme Ltd

Hertford Road,

Hoddesdon,

Hertfordshire EN11 9BU,

United Kingdom

EU/1/06/358/001-008

EU/1/06/358/018-021

25.5.2012

22.5.2012

Tamiflu

Roche Registration Limited

6 Falcon Way,

Shire Park,

Welwyn Garden City,

AL7 1TW,

United Kingdom

EU/1/02/222/001-005

24.5.2012

22.5.2012

Tamiflu

Roche Registration Limited

6 Falcon Way,

Shire Park,

Welwyn Garden City,

AL7 1TW,

United Kingdom

EU/1/02/222/001-005

25.5.2012

22.5.2012

Votrient

Glaxo Group Limited

Berkeley Avenue,

Greenford,

Middlesex UB6 0NN,

United Kingdom

EU/1/10/628/001-004

25.5.2012

25.5.2012

Benlysta

Glaxo Group Limited

Glaxo Wellcome House,

Berkeley Avenue,

Greenford,

Middlesex UB6 0NN,

United Kingdom

EU/1/11/700/001-002

30.5.2012

25.5.2012

Betaferon

Bayer Pharma AG

D - 13342 Berlin,

Deutschland

EU/1/95/003/003-012

30.5.2012

25.5.2012

Busilvex

Pierre Fabre Médicament

45, Place Abel Gance,

92654 Boulogne Billancourt Cedex,

France

EU/1/03/254/002

31.5.2012

25.5.2012

Clopidogrel Teva Pharma B.V.

Teva Pharma B.V.

Computerweg 10,

3542 DR Utrecht,

Nederland

EU/1/10/649/001-016

30.5.2012

25.5.2012

Conbriza

Pfizer Limited

Ramsgate Road,

Sandwich,

Kent CT13 9NJ,

United Kingdom

EU/1/09/511/001-005

31.5.2012

25.5.2012

DuoCover

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park,

Sanderson Road,

Uxbridge UB8 1DH,

United Kingdom

EU/1/10/623/001-015

30.5.2012

25.5.2012

Ecalta

Pfizer Limited

Ramsgate Road,

Sandwich,

Kent CT13 9NJ,

United Kingdom

EU/1/07/416/001-002

31.5.2012

25.5.2012

Fosavance

Merck Sharp & Dohme Ltd

Hertford Road,

Hoddesdon,

Hertfordshire EN11 9BU,

United Kingdom

EU/1/05/310/001-009

30.5.2012

25.5.2012

Irbesartan Teva

Teva Pharma B.V.

Computerweg 10,

3542 DR Utrecht,

Nederland

EU/1/09/576/001-039

30.5.2012

25.5.2012

Ixiaro

Intercell AG

Campus Vienna Biocenter 3

A-1030 Wien,

Österreich

EU/1/08/501/001-002

31.5.2012

25.5.2012

Keppra

UCB Pharma SA.

Allée de la Recherche 60,

1070 Bruxelles,

Belgique/Researchdreef, 60,

Brussel 1070,

België

EU/1/00/146/001-032

1.6.2012

25.5.2012

Kinzalkomb

Bayer Pharma AG

Berlin 13342,

Deutschland

EU/1/02/214/001-015

31.5.2012

25.5.2012

Kinzalmono

Bayer Pharma AG

Berlin 13342,

Deutschland

EU/1/98/091/001-014

31.5.2012

25.5.2012

Kuvan

Merck Serono Europe Limited

56 Marsh Wall,

London E14 9TP,

United Kingdom

EU/1/08/481/001-003

30.5.2012

25.5.2012

Lamivudine / Zidovudine Teva

Teva Pharma B.V.

Computerweg 10,

3542 DR Utrecht,

Nederland

EU/1/10/663/001-002

1.6.2012

25.5.2012

Micardis

Boehringer Ingelheim International GmbH

Binger Strasse 173-

D - 55216 Ingelheim am Rhein,

Deutschland

EU/1/98/090/001-022

31.5.2012

25.5.2012

MicardisPlus

Boehringer Ingelheim International GmbH

Binger Strasse 173-

D - 55216 Ingelheim am Rhein,

Deutschland

EU/1/02/213/001-023

31.5.2012

25.5.2012

Neulasta

Amgen Europe B.V.

Minervum 7061,

NL-4817 ZK Breda,

Nederland

EU/1/02/227/001-002

EU/1/02/227/004

1.6.2012

25.5.2012

Nevirapine Teva

Teva Pharma B.V.

Computerweg 10,

3542 DR Utrecht,

Nederland

EU/1/09/598/001-004

30.5.2012

25.5.2012

Onduarp

Boehringer Ingelheim International GmbH

Binger Str. 173,

D-55216 Ingelheim am Rhein,

Deutschland

EU/1/11/729/001-006

30.5.2012

25.5.2012

Optaflu

Novartis Vaccines and Diagnostics GmbH

Emil-von-Behring-Strasse 76,

D-35041 Marburg,

Deutschland

EU/1/07/394/001-009

31.5.2012

25.5.2012

Osseor

Les Laboratoires Servier

50, rue Carnot,

92284 Suresnes cedex,

France

EU/1/04/287/001-006

30.5.2012

25.5.2012

Pradaxa

Boehringer Ingelheim International GmbH

Binger Strasse 173,

D-55216 Ingelheim am Rhein,

Deutschland

EU/1/08/442/001-014

1.6.2012

25.5.2012

Pritor

Bayer Pharma AG

13342 Berlin,

Deutschland

EU/1/98/089/001-022

30.5.2012

25.5.2012

PritorPlus

Bayer Pharma AG

13342 Berlin,

Deutschland

EU/1/02/215/001-021

30.5.2012

25.5.2012

Protelos

Les Laboratoires Servier

50, rue Carnot,

92284 Suresnes cedex,

France

EU/1/04/288/001-006

 

25.5.2012

Rasilamlo

Novartis Europharm Ltd

Wimblehurst Road,

Horsham,

West Sussex, RH12 5AB,

United Kingdom

EU/1/11/686/001-056

30.5.2012

25.5.2012

Rasilez

Novartis Europharm Ltd

Wimblehurst Road,

Horsham,

West Sussex RH12 5AB,

United Kingdom

EU/1/07/405/001-040

30.5.2012

25.5.2012

Rasilez HCT

Novartis Europharm Ltd

Wimblehurst Road,

Horsham,

West Sussex RH12 5AB,

United Kingdom

EU/1/08/491/001-080

31.5.2012

25.5.2012

Rasitrio

Novartis Europharm Limited

Wimblehurst Road,

Horsham,

West Sussex, RH12 5AB,

United Kingdom

EU/1/11/730/001-060

31.5.2012

25.5.2012

Riprazo

Novartis Europharm Ltd

Wimblehurst Road,

Horsham,

West Sussex RH12 5AB,

United Kingdom

EU/1/07/409/001-040

30.5.2012

25.5.2012

Riprazo HCT

Novartis Europharm Limited

Wimblehurst Road,

Horsham,

West Sussex, RH12 5AB,

United Kingdom

EU/1/11/680/001-080

1.6.2012

25.5.2012

Rivastigmine Actavis

Actavis Group PTC ehf.

ReykjavÍkurvegur 76-78,

Hafnarfjörður 220,

Iceland

EU/1/11/693/001-016

1.6.2012

25.5.2012

RoActemra

Roche Registration Limited

6 Falcon Way,

Shire Park,

Welwyn Garden City,

AL7 1TW,

United Kingdom

EU/1/08/492/001-006

31.5.2012

25.5.2012

Sprimeo

Novartis Europharm Ltd

Wimblehurst Road,

Horsham,

West Sussex RH12 5AB,

United Kingdom

EU/1/07/407/001-040

31.5.2012

25.5.2012

Sprimeo HCT

Novartis Europharm Limited

Wimblehurst Road,

Horsham,

West Sussex, RH12 5AB,

United Kingdom

EU/1/11/683/001-080

1.6.2012

25.5.2012

Temozolomide Hospira

Hospira UK Ltd.

Queensway,

Royal Leamington Spa,

Warwickshire CV31 3RW,

United Kingdom

EU/1/10/615/001-002

EU/1/10/615/005-006

EU/1/10/615/009-010

EU/1/10/615/013-014

EU/1/10/615/017-018

EU/1/10/615/021-022

31.5.2012

25.5.2012

Tysabri

Elan Pharma International Ltd.

Treasury Building,

Lower Grand Canal Street,

Dublin 2,

IRELAND

EU/1/06/346/001

31.5.2012

25.5.2012

Vantavo

Merck Sharp & Dohme Ltd.

Hertford Road,

Hoddesdon,

Hertfordshire EN11 9BU,

United Kingdom

EU/1/09/572/001-004

EU/1/09/572/006-008

30.5.2012

25.5.2012

Victoza

Novo Nordisk A/S

Novo Allé,

DK-2880 Bagsvaerd,

Danmark

EU/1/09/529/001-005

31.5.2012

25.5.2012

Vistide

Gilead Sciences International Limited

Cambridge,

CB21 6GT,

United Kingdom

EU/1/97/037/001

31.5.2012

25.5.2012

Volibris

Glaxo Group Ltd

Greenford,

Middlesex UB6 0NN,

United Kingdom

EU/1/08/451/001-004

30.5.2012

25.5.2012

Votrient

Glaxo Group Limited

Berkeley Avenue,

Greenford,

Middlesex UB6 0NN,

United Kingdom

EU/1/10/628/001-004

31.5.2012

25.5.2012

Xolair

Novartis Europharm Ltd

Wimblehurst Road,

Horsham,

West Sussex RH12 5AB,

United Kingdom

EU/1/05/319/001-010

30.5.2012

31.5.2012

Lamivudine Teva

Teva Pharma B.V.

Computerweg 10,

3542 DR Utrecht,

Nederland

EU/1/09/566/001-005

4.6.2012

31.5.2012

Peyona

CHIESI FARMACEUTICI SpA

Via Palermo 26/A,

I-43100 Parma,

ITALIA

EU/1/09/528/001-002

4.6.2012

31.5.2012

Temozolomide Teva

Teva Pharma B.V.

Computerweg 10,

DR Utrecht 3542,

Nederland

EU/1/09/606/001-012

4.6.2012


—   Retragerea unei autorizații de introducere pe piață (articolul 13 din Regulamentul (CE) nr. 726/2004 al Parlamentului European și al Consiliului)

Data deciziei

Denumirea medicamentului

Titularul autorizației de introducere pe piață

Numărul de înregistrare în Registrul comunitar

Data notificării

10.5.2012

Valtropin

BioPartners GmbH

Kaiserpassage 11 -

D-72764 Reutlingen,

Deutschland

EU/1/06/335/001

14.5.2012

25.5.2012

Docefrez

Sun Pharmaceuticals Industries Europe B.V.

Polarisavenue 87,

2132 JH Hoofddorp,

Nederland

EU/1/10/630/001-002

31.5.2012

25.5.2012

Intrinsa

Warner Chilcott UK Ltd

Old Belfast Road,

Millbrook, Larne,

County Antrim BT40 2SH,

United Kingdom

EU/1/06/352/001-003

31.5.2012


—   Anularea suspendării unei autorizații de introducere pe piață (articolul 20 din Regulamentul (CE) nr. 726/2004 al Parlamentului European și al Consiliului)

Data deciziei

Denumirea medicamentului

Titularul autorizației de introducere pe piață

Numărul de înregistrare în Registrul comunitar

Data notificării

25.5.2012

Angiox

The Medicines Company UK Ltd

115 L Milton Park,

Abingdon,

Oxfordshire, OX14 4SA,

United Kingdom

EU/1/04/289/001

31.5.2012

25.5.2012

Caelyx

Janssen-Cilag International NV

Turnhoutseweg 30,

B-2340 Beerse,

België

EU/1/96/011/001-004

31.5.2012

25.5.2012

Luminity

Lantheus MI UK Limited

Festival House -

39 Oxford Street -

Newbury -

Berkshire RG14 1JG -

United Kingdom

EU/1/06/361/001-002

31.5.2012

25.5.2012

Mepact

IDM PHARMA SAS

11-15 quai De Dion Bouton,

92816 Puteaux Cedex,

France

EU/1/08/502/001

1.6.2012

25.5.2012

Soliris

Alexion Europe S.A.S.

25, boulevard de l'Amiral Bruix,

75016 Paris,

France

EU/1/07/393/001

31.5.2012

25.5.2012

Torisel

Pfizer Limited

Ramsgate Road,

Sandwich,

Kent, CT13 9NJ,

United Kingdom

EU/1/07/424/001

30.5.2012

25.5.2012

VELCADE

Janssen-Cilag International NV

Turnhoutseweg 30,

B-2340 Beerse,

België

EU/1/04/274/001-002

31.5.2012

31.5.2012

Ceplene

EpiCept GmbH

Goethestrasse 4,

D-80336 München,

Deutschland

EU/1/08/477/001

4.6.2012


—   Modificarea unei autorizații de introducere pe piață (articolul 38 din Regulamentul (CE) nr. 726/2004 al Parlamentului European și al Consiliului): Acceptat

Data deciziei

Denumirea medicamentului

Titularul autorizației de introducere pe piață

Numărul de înregistrare în Registrul comunitar

Data notificării

10.5.2012

Circovac

Merial

29 Avenue Tony Garnier,

69007 Lyon,

France

EU/2/07/075/001-004

14.5.2012

10.5.2012

Netvax

Intervet International B.V.

Wim de Körverstraat 35,

5831 AN Boxmeer,

Nederland

EU/2/09/093/001-002

14.5.2012

22.5.2012

Convenia

Pfizer Ltd

Ramsgate Road,

Sandwich,

Kent CT 13 9NJ,

United Kingdom

EU/2/06/059/001-002

30.5.2012

22.5.2012

Equip WNV

Pfizer Limited

Ramsgate Road,

Sandwich,

Kent CT13 9NJ,

United Kingdom

EU/2/08/086/001-003

25.5.2012

22.5.2012

PRILACTONE

CEVA SANTE ANIMALE

10 avenue de la Ballastière,

33500 Libourne,

France

EU/2/07/074/001-006

25.5.2012

25.5.2012

Onsior

Novartis Animal Health UK Ltd

Frimley Business Park,

Frimley/Camberley,

Surrey, GU16 7SR,

United Kingdom

EU/2/08/089/001-021

1.6.2012

25.5.2012

Suprelorin

VIRBAC S.A.

1ère Avenue 2065 m L.I.D. -

06516 Carros -

France

EU/2/07/072/001-004

1.6.2012

Oricine este interesat să consulte raportul public de evaluare al medicamentului în cauză și deciziile aferente este invitat să contacteze:

The European Medicines Agency

7, Westferry Circus,

Canary Wharf

UK - LONDON E14 4H

(1)  JO L 136, 30.4.2004, p. 1.